Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Goudemand · SciRah

Researcher profile · Semantic Scholar

J. Goudemand

Share profile

J. Goudemand — researcher profile on SciRah

h-index: 40
Works: 222
Citations: 7,863

Most-cited papers

Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD).
A. Goodeve, J. Eikenboom, G. Castaman, F. Rodeghiero +20 more
2007Blood413 citations Open access
Semantic Scholar
Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A.
J. Goudemand, C. Rothschild, V. Demiguel, Christine Vinciguerrat +6 more
2006Blood309 citations Open access
Semantic Scholar
Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD.
G. Castaman, S. Lethagen, A. Federici, A. Tosetto +17 more
2008Blood210 citations Open access
Semantic Scholar
Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD).
S. Haberichter, G. Castaman, U. Budde, I. Peake +17 more
2008Blood184 citations Open access
Semantic Scholar
Recombinant factor VIII products and inhibitor development in previously untreated boys with severe hemophilia A.
T. Calvez, H. Chambost, S. Claeyssens-Donadel, R. d'Oiron +8 more
2014Blood159 citations
Semantic Scholar
Von Willebrand Factor Multimers during Transcatheter Aortic-Valve Replacement.
E. van Belle, A. Rauch, F. Vincent, E. Robin +38 more
2016New England Journal of Medicine141 citations
Semantic Scholar
VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease.
J. Eikenboom, A. Federici, R. Dirven, G. Castaman +8 more
2013Blood114 citations Open access
Semantic Scholar
Variations in glycosylation of von Willebrand factor with O-linked sialylated T antigen are associated with its plasma levels.
Carina J. M. van Schooten, C. Denis, T. Lisman, Jeroen Eikenboom +6 more
2007Blood93 citations Open access
Semantic Scholar
Expanding the Mutation Spectrum Affecting αIIbβ3 Integrin in Glanzmann Thrombasthenia: Screening of the ITGA2B and ITGB3 Genes in a Large International Cohort
A. Nurden, Xavier Pillois, M. Fiore, M. Alessi +22 more
2015Human Mutation92 citations Open access
Semantic Scholar
Von Willebrand factor as a biological sensor of blood flow to monitor percutaneous aortic valve interventions.
E. van Belle, A. Rauch, A. Vincentelli, E. Jeanpierre +21 more
2015Circulation Research85 citations Open access
Semantic Scholar
A Laboratory Phenotype/Genotype Correlation of 1167 French Patients From 670 Families With von Willebrand Disease
A. Veyradier, P. Boisseau, É. Fressinaud, C. Caron +12 more
2016Medicine70 citations Open access
Semantic Scholar
Solvent‐detergent filtered (S/D‐F) fresh frozen plasma and cryoprecipitate minipools prepared in a newly designed integral disposable processing bag system
M. Elekiaby, M. Sayed, C. Caron, S. Burnouf +9 more
2010Transfusion Medicine61 citations
Semantic Scholar
Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A
T. Calvez, H. Chambost, R. d'Oiron, Vincent Dalibard +8 more
2017Haematologica58 citations Open access
Semantic Scholar
Functional Impairment of Von Willebrand Factor in Hypertrophic Cardiomyopathy: Relation to Rest and Exercise Obstruction
T. Letourneau, S. Susen, C. Caron, A. Millaire +12 more
2008Circulation58 citations Open access
Semantic Scholar
Clinical and prognostic implications of low or high level of von Willebrand factor in patients with Waldenstrom macroglobulinemia.
B. Hivert, C. Caron, S. Petit, C. Charpy +9 more
2012Blood55 citations
Semantic Scholar
FXI concentrate use and risk of thrombosis
P. Bolton-Maggs, J. Goudemand, C. Hermans, M. Makris +1 more
2014Haemophilia51 citations
Semantic Scholar
The impact of bleeding history, von Willebrand factor and PFA–100® on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM‐1VWD
G. Castaman, A. Tosetto, A. Goodeve, Augusto B. Federici +13 more
2010British Journal of Haematology47 citations Open access
Semantic Scholar
Antibody-based prevention of von Willebrand factor degradation mediated by circulatory assist devices
A. Rauch, P. Legendre, O. Christophe, J. Goudemand +5 more
2014Thrombosis and Haemostasis43 citations
Semantic Scholar
Pharmacokinetics and pharmacodynamics of a new highly secured fibrinogen concentrate
C. Négrier, C. Rothschild, J. Goudemand, J. Borg +6 more
2008Journal of Thrombosis and Haemostasis39 citations Open access
Semantic Scholar
Factor XI replacement for inherited factor XI deficiency in routine clinical practice: results of the HEMOLEVEN prospective 3-year postmarketing study
F. Bauduer, E. de Raucourt, C. Boyer-Neumann, M. Trossaert +9 more
2015Haemophilia38 citations Open access
Semantic Scholar
αIIbβ3 integrin: new allelic variants in Glanzmann thrombasthenia, effects on ITGA2B and ITGB3 mRNA splicing, expression, and structure–function
V. Jallu, M. Dusseaux, S. Panzer, M. Torchet +4 more
2010Human Mutation36 citations
Semantic Scholar
Intra-patient variability of thromboelastographic parameters following in vivo and ex vivo administration of recombinant activated factor VII in haemophilia patients. A multi-centre, randomised trial
G. Kenet, C. Stenmo, A. Blemings, W. Wegert +5 more
2009Thrombosis and Haemostasis35 citations
Semantic Scholar
Risk of inhibitors in haemophilia and the type of factor replacement
J. Goudemand, Y. Laurian, T. Calvez
2006Current opinion in hematology35 citations
Semantic Scholar
Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS‐IPS, an international and collaborative cross‐sectional study
A. Tosetto, Zahra Badiee, M. Baghaipour, L. Baronciani +31 more
2020Journal of Thrombosis and Haemostasis30 citations Open access
Semantic Scholar
New findings on inhibitor development: from registries to clinical studies
F. Peyvandi, C. Ettingshausen, J. Goudemand, V. Jiménez-Yuste +2 more
2017Haemophilia29 citations
Semantic Scholar
Mutations in the A3 domain of von Willebrand factor inducing combined qualitative and quantitative defects in the protein.
P. Legendre, A. Navarrete, J. Rayes, C. Casari +9 more
2013Blood28 citations Open access
Semantic Scholar
Meningococcemia and purpura fulminans in adults: acute deficiencies of proteins C and S and early treatment with antithrombin III concentrates
F. Fourrier, P. Lestavel, C. Chopin, A. Marey +3 more
2007Intensive Care Medicine28 citations
Semantic Scholar
Evaluation of an Automated von Willebrand Factor Activity Assay in von Willebrand Disease
M. Trossaërt, C. Ternisien, A. Lefrançois, L. Llopis +4 more
2011Clinical and applied thrombosis/hemostasis27 citations
Semantic Scholar
Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies
P. Volkers, K. Hanschmann, T. Calvez, H. Chambost +11 more
2019Haemophilia26 citations
Semantic Scholar
Properties of a concentrated minipool solvent‐detergent treated cryoprecipitate processed in single‐use bag systems
T. Burnouf, C. Caron, M. Radosevich, H. Goubran +2 more
2008Haemophilia25 citations
Semantic Scholar
Mutational analysis of the von Willebrand factor gene in type 1 von Willebrand disease using conformation sensitive gel electrophoresis: a comparison of fluorescent and manual techniques.
Mohammad Hashemi Soteh, I. Peake, L. Marsden, J. Anson +7 more
2007Haematologica23 citations Open access
Semantic Scholar
Impact of choice of treatment for bleeding episodes on inhibitor outcome in patients with mild/moderate hemophilia a and inhibitors.
R. d'Oiron, F. Volot, J. Reynaud, K. Peerlinck +11 more
2006Seminars in hematology (Print)23 citations
Semantic Scholar
Rituximab in postpartum-related acquired hemophilia.
H. Maillard, D. Launay, E. Hachulla, J. Goudemand +4 more
2006American Journal of Medicine22 citations Open access
Semantic Scholar
Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS.
L. Baronciani, I. Peake, R. Schneppenheim, A. Goodeve +30 more
2021Blood Advances21 citations Open access
Semantic Scholar
FranceCoag: a 22-year prospective follow-up of the national French cohort of patients with inherited bleeding disorders
A. Doncarli, V. Demiguel, I. Guseva Canu, V. Goulet +13 more
2018European Journal of Epidemiology20 citations
Semantic Scholar
Management of von Willebrand disease with a factor VIII‐poor von Willebrand factor concentrate: Results from a prospective observational post‐marketing study
J. Goudemand, F. Bridey, S. Claeyssens, N. Itzhar-Baïkian +8 more
2020Journal of Thrombosis and Haemostasis18 citations Open access
Semantic Scholar
The common VWF single nucleotide variants c.2365A>G and c.2385T>C modify VWF biosynthesis and clearance.
Ahmad Mufti, K. Ogiwara, L. Swystun, J. Eikenboom +8 more
2018Blood Advances18 citations Open access
Semantic Scholar
Relevance of platelet desialylation and thrombocytopenia in type 2B von Willebrand disease: preclinical and clinical evidence
A. Dupont, Christelle Soukaseum, Mathilde Cheptou, F. Adam +19 more
2019Haematologica17 citations Open access
Semantic Scholar
Polymorphic variation within the VWF gene contributes to the failure to detect mutations in patients historically diagnosed with type 1 von Willebrand disease from the MCMDM-1VWD cohort
D. Hampshire, G. J. Burghel, J. Goudemand, Laura Bouvet +5 more
2010Haematologica17 citations Open access
Semantic Scholar
EQOFIX: a combined economic and quality‐of‐life study of hemophilia B treatments in France
B. Polack, T. Calvez, H. Chambost, C. Rothschild +6 more
2015Transfusion16 citations Open access
Semantic Scholar
Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa)
A. Tiede, U. Friedrich, C. Stenmo, G. Allen +11 more
2011Journal of Thrombosis and Haemostasis16 citations Open access
Semantic Scholar
von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS.
M. Pagliari, U. Budde, L. Baronciani, P. Eshghi +28 more
2023Journal of Thrombosis and Haemostasis15 citations Open access
Semantic Scholar
Hemostatic profile of infants with spontaneous prematurity: can we predict intraventricular hemorrhage development?
A. Hochart, Alexandra Nuytten, A. Pierache, A. Bauters +4 more
2019Italian Journal of Pediatrics14 citations Open access
Semantic Scholar
A novel ELISA-based diagnosis of acquired von Willebrand disease with increased VWF proteolysis
A. Rauch, C. Caron, F. Vincent, E. Jeanpierre +15 more
2016Thrombosis and Haemostasis13 citations
Semantic Scholar
Inhibitor development in haemophilia A: the role of von Willebrand factor/factor VIII concentrates
J. Goudemand
2007Haemophilia13 citations
Semantic Scholar
The challenge of genetically unresolved haemophilia A patients: Interest of the combination of whole F8 gene sequencing and functional assays
Fanny Lassalle, Y. Jourdy, L. Jouan, L. Swystun +6 more
2020Haemophilia12 citations
Semantic Scholar
Summary report of the First International Conference on inhibitors in haemophilia A.
S. Lacroix-Desmazes, D. Scott, J. Goudemand, M. H. van den Berg +20 more
2017Blood transfusion = Trasfusione del sangue12 citations
Semantic Scholar
Key insights to understand the immunogenicity of FVIII products
J. Goudemand, F. Peyvandi, S. Lacroix-Desmazes
2016Thrombosis and Haemostasis12 citations
Semantic Scholar
Diluted Russell viper-venom time improves identification of antiphospholipid syndrome in a lupus anticoagulant-positive patient population
M. Lambert, Gisele Ferrard-Sasson, S. Dubucquoi, E. Hachulla +5 more
2009Thrombosis and Haemostasis10 citations
Semantic Scholar
Costs and management of patients with hemophilia A in France: the Hemraude study
C. Laurendeau, J. Goudemand, M. Trossaert, B. Polack +4 more
2021European Journal of Health Economics9 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

I. Peake×11
Invite
I. Peake — researcher profile on SciRah
C. Caron×11
Invite
C. Caron — researcher profile on SciRah
S. Susen×11
Invite
S. Susen — researcher profile on SciRah
A. Goodeve×10
Invite
A. Goodeve — researcher profile on SciRah

×10

Invite

J. Eikenboom — researcher profile on SciRah

Invite

U. Budde — researcher profile on SciRah

R. Schneppenheim×9

Invite

R. Schneppenheim — researcher profile on SciRah

Invite

G. Castaman — researcher profile on SciRah

Invite

H. Chambost — researcher profile on SciRah

Invite

A. Federici — researcher profile on SciRah

Invite

T. Calvez — researcher profile on SciRah

M. Trossaert×7

Invite

M. Trossaert — researcher profile on SciRah